Around the Net

Biogen's New Alzheimer's Drug Could Offer Turning Point

After decades of failed treatments, a new drug called Lequmbi is offering some hope in the fight against Alzheimer's disease. "The medicine’s benefits are modest — it slowed cognitive decline by 27% in an 18-month clinical study run by the Japanese drug firm Eisai and its Cambridge partner Biogen …

Read the whole story at Boston Globe »

Next story loading loading..

Discover Our Publications